2003
DOI: 10.1074/jbc.m210717200
|View full text |Cite
|
Sign up to set email alerts
|

Cell Biology of the Human Thiamine Transporter-1 (hTHTR1)

Abstract: The human thiamine transporter hTHTR1 is involved in the cellular accumulation of thiamine (vitamin B1) in many tissues. Thiamine deficiency disorders, such as thiamine-responsive megaloblastic anemia (TRMA), which is associated with specific mutations within hTHTR1, likely impairs the functionality and/or intracellular targeting of hTHTR1. Unfortunately, nothing is known about the mechanisms that control the intracellular trafficking or membrane targeting of hTHTR1. To identify molecular determinants involved… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
24
0

Year Published

2003
2003
2019
2019

Publication Types

Select...
6
2

Relationship

3
5

Authors

Journals

citations
Cited by 61 publications
(26 citation statements)
references
References 36 publications
2
24
0
Order By: Relevance
“…Furthermore, measurements of steady-state targeting of hTHTR2 in the presence of microtubule-disrupting agents, or a cytoplasmic dynein inhibitor, disrupted the polarized expression of the full-length hTHTR2 polypeptide at the apical membrane domain. Comparison of these results with data obtained previously for hRFC and hTHTR1 (16,17) underscore commonalities shared between all members of the SLC19A gene family in regard to the structural features essential for cell surface delivery, despite their divergent targeting to discrete plasma membrane domains.…”
Section: Targeting and Trafficking Of The Human Thiamine Transporter-supporting
confidence: 57%
See 1 more Smart Citation
“…Furthermore, measurements of steady-state targeting of hTHTR2 in the presence of microtubule-disrupting agents, or a cytoplasmic dynein inhibitor, disrupted the polarized expression of the full-length hTHTR2 polypeptide at the apical membrane domain. Comparison of these results with data obtained previously for hRFC and hTHTR1 (16,17) underscore commonalities shared between all members of the SLC19A gene family in regard to the structural features essential for cell surface delivery, despite their divergent targeting to discrete plasma membrane domains.…”
Section: Targeting and Trafficking Of The Human Thiamine Transporter-supporting
confidence: 57%
“…To determine the level of hTHTR2 expression in the stable cell lines, we performed semi-quantitative RT-PCR (17). Functionality of hTHTR2 was determined by [ 3 H]thiamine uptake assay.…”
Section: Methodsmentioning
confidence: 99%
“…To achieve sufficient spatial and temporal resolution to track individual structures, we used a scanning video rate confocal microscope and an oil immersion objective to monitor hSVCT1-YFP dynamics in cover glass-attached HuTu-80 cells, a preparation more amenable for trafficking analyses than water immersion imaging of filter-grown MDCK or CaCo-2 cells (18,20). First, we generated a stable hSVCT1-YFP expressing HuTu-80 cell line by G418 selection (Fig.…”
Section: Role Of Sequence and Topology Of The C-terminal Vfkg Mo-mentioning
confidence: 99%
“…The full-length hS-VCT1-YFP fusion protein and truncated hSVCT1-YFP constructs were generated using the specific primer combinations defined in Table I under PCR conditions outlined previously (18). PCR products and the EYFP-N1 vector were subsequently digested with the restriction enzymes HindIII and SacII, the products were gel-isolated and ligated together to generate in-frame fusion proteins with enhanced yellow fluorescent protein (YFP) fused to the C terminus of each construct.…”
Section: Materials-[mentioning
confidence: 99%
“…8 Distinct mutations in SLC19A2 have been described in many families 9 and lead to either a lack of the protein product or an altered structure of the protein so that it is not properly targeted to its site of function on the cell membrane. 9,10 TRMA is characterized by anemia, deafness, and diabetes mellitus. Hematological features consist of the unique combination of megaloblastic changes and the ring sideroblast abnormality, with variable degrees of neutropenia and thrombocytopenia.…”
Section: Discussionmentioning
confidence: 99%